Viewing StudyNCT00112775



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00112775
Status: UNKNOWN
Last Update Posted: 2011-06-07
First Post: 2005-06-02

Brief Title: BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
Sponsor: Jonsson Comprehensive Cancer Center
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
chronic phase chronic myelogenous leukemia View
chronic myelogenous leukemia BCR-ABL1 positive View
relapsing chronic myelogenous leukemia View